Commerce Bank’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$462K Hold
12,437
﹤0.01% 993
2026
Q1
$421K Sell
12,437
-219
-2% -$6.21K ﹤0.01% 999
2025
Q4
$344K Buy
12,656
+3,497
+38% +$123K ﹤0.01% 1026
2025
Q3
$368K Sell
9,159
-445
-5% -$16.7K ﹤0.01% 988
2025
Q2
$319K Buy
9,604
+1,405
+17% +$42.6K ﹤0.01% 1014
2025
Q1
$240K Buy
+8,199
New +$272K ﹤0.01% 1082
2024
Q4
Sell
-6,069
Closed -$270K 1178
2024
Q3
$270K Sell
6,069
-170
-3% -$7.72K ﹤0.01% 1088
2024
Q2
$269K Buy
+6,239
New +$225K ﹤0.01% 1060

Other funds holding AGIO

Commerce Bank's AGIO Position: Q2 2026 in Review

Commerce Bank held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 12,437 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Commerce Bank first reported a position in AGIO in Q2 2024 and has held it in 8 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Commerce Bank held 12,437 shares of Agios Pharmaceuticals worth $462K as of Q2 2026.
  • Commerce Bank left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #993 holding.
  • Commerce Bank first reported a position in Agios Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.